Screening and Treatment of Glaucoma

Screening and Treatment of Glaucoma
Through a partnership with the Effective Health Care Program, the U.S. Preventive Services Task Force is offering an opportunity for public comment on the key questions of the evidence on Screening and Treatment of Glaucoma. To provide comments, go to http://www.ahrq.gov/clinic/tfcomment.htm and select "Comparative Effectiveness of Screening for Glaucoma" or "Comparative Effectiveness of Treatment for Glaucoma."

As the USPSTF works to increase the transparency of its methods and processes, additional opportunities for public comment will be available. Information about these opportunities will be posted on http://www.preventiveservices.ahrq.gov.

Opportunities for Public Comment
Identifying Research Priorities for Clinical Preventive Services

Since first established in 1984, the U.S. Preventive Services Task Force (USPSTF) has played an important role in identifying what is known about clinical preventive services. The USPSTF, an independent expert panel supported by AHRQ, makes evidence-based recommendations about the delivery of clinical preventive services for the general U.S. population. For many topics (about one-third), there is not enough evidence for the USPSTF to determine whether the potential benefits outweigh the potential harms of performing a particular clinical preventive service. For these topics, the USPSTF issues "I" Statements (meaning "Insufficient evidence").

The USPSTF has been charged with the task of developing a process for establishing research priorities about clinical preventive services for which the USPSTF has issued "I" Statements. The USPSTF has proposed methods for prioritization that could be applied consistently and objectively across all topics, and is now seeking your assessment of these methods.

In particular, the USPSTF is soliciting feedback on the following:

The method for evaluating Potential Preventable Burden, Harms, and Costs.
Domains other than Potential Preventable Burden, Harms, and Costs that the USPSTF should consider in determining the prioritization of research for clinical preventive services.
The process for identifying critical gaps in the evidence.
Other factors that the USPSTF should consider in assessing research feasibility.
Select for Identifying Research Priorities for Clinical Preventive Services (PDF file, 140 KB; PDF Help).
http://www.ahrq.gov/clinic/iwgpropmeth.htm


Comments must be received by 5:00 p.m., EST, on May 14, 2010.



Screening and Treatment of Glaucoma
Through a partnership with the Effective Health Care Program, the USPSTF is offering an opportunity for public comment on the key questions of the evidence on Screening and Treatment of Glaucoma. To provide comments, please go to http://effectivehealthcare.ahrq.gov/index.cfm/research-available-for-comment/, and select "Comparative Effectiveness of Screening for Glaucoma" or "Comparative Effectiveness of Treatment for Glaucoma."

Current as of April 2010


------------------
Internet Citation:

Opportunity for Public Comment. U.S. Preventive Services Task Force. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/tfcomment.htm

------------------